Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Rev Esp Enferm Dig ; 101(2): 91-3, 94-6, 2009 Feb.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-19335044

RESUMO

INTRODUCTION: There are two kinds of actinic proctitis--one is acute and self-limited, and lasts about 3 months; the other is chronic and develops months to years after radiation therapy. The incidence of chronic actinic proctitis is about 5-20% of radiated prostate tumors. OBJECTIVE: To evaluate the effectiveness of argon plasma coagulation in the treatment of chronic actinic proctitis. MATERIAL AND METHOD: A retrospective search of patients with the diagnosis of actinic proctitis. The number of argon plasma coagulation therapies needed to achieve the symptom resolution was analyzed. RESULTS: We found 22 patients with a diagnosis of actinic proctitis. Nineteen were males (86.7%) and three (13.6%) were females. Nineteen patients (86.4%) had a diagnosis of prostate adenocarcinoma, one had a diagnosis of squamous-cell cervix carcinoma (4.5%), and two had a diagnosis of endometrial carcinoma (9.1%). The mean number of coagulation sessions needed for symptom resolution was 2.58 (absolute range 1-7) with a median of 2 sessions. CONCLUSION: Multiple treatments are described in the literature. None of them have shown promising results. Our results suggest that argon plasma coagulation is effective in the treatment of this condition, and achieves a rapid and sustained response with few sessions and a good safety profile.


Assuntos
Hemorragia Gastrointestinal/cirurgia , Fotocoagulação a Laser , Proctite/cirurgia , Lesões por Radiação/cirurgia , Adenocarcinoma/radioterapia , Idoso , Argônio , Carcinoma de Células Escamosas/radioterapia , Feminino , Hemorragia Gastrointestinal/etiologia , Hemostasia Cirúrgica/instrumentação , Humanos , Masculino , Proctite/complicações , Neoplasias da Próstata/radioterapia , Lesões por Radiação/complicações , Estudos Retrospectivos , Resultado do Tratamento , Neoplasias do Colo do Útero/radioterapia , Neoplasias Uterinas/radioterapia
2.
Rev Esp Enferm Dig ; 87(8): 564-8, 1995 Aug.
Artigo em Espanhol | MEDLINE | ID: mdl-7577104

RESUMO

OBJECTIVE: A long term retrospective study comparing endoscopic lesions and their relationship with symptoms and histological lesions of postoperative Alkaline Reflux Gastritis (ARG) between partial gastrectomy Billroth II (n = 25) and the Roux-en-Y (n = 36) is presented. PATIENTS AND METHODS: In patients operated on with both techniques the clinical, endoscopic and histological aspects are studied. RESULTS: The patients operated on with the Billroth II technique present a higher frequency of bile in the gastric remnant and mucosal lesions in the endoscopic study (p < 0.001) compared with the Roux-en-Y group. Bile and mucosal lesions on the gastric stump are more common with symptoms and histological lesions of postoperative ARG. CONCLUSIONS: The endoscopic evaluation is a valid and reliable examination in the diagnosis and follow up of postoperative ARG.


Assuntos
Refluxo Duodenogástrico/complicações , Gastrectomia/efeitos adversos , Gastrite/diagnóstico , Gastroscopia , Adulto , Idoso , Feminino , Seguimentos , Gastrectomia/métodos , Gastrite/etiologia , Humanos , Concentração de Íons de Hidrogênio , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
3.
Rev Esp Enferm Dig ; 91(8): 541-8, 1999 Aug.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-10491486

RESUMO

OBJECTIVE: primary gastric B-cell lymphoma of the mucosa-associated lymphoid tissue type has been linked to infection of the gastric mucosa with Helicobacter pylori. The eradication of this pathogen with antibiotics can lead to regression of this type of lymphoma. The objective of this study was to describe the clinical, endoscopic and histologic evolution in 6 patients with primary gastric B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with eradication of H. pylori. METHOD: descriptive study of a retrospective case series. Patients with low-grade gastric mucosa-associated lymphoid tissue type lymphoma were initially treated with eradication therapy for H. pylori. We evaluated their clinical, endoscopic and histologic course in sequential follow-up visits after initial therapy. RESULTS: six patients who satisfied all selection criteria were studied. In five of six patients H. pylori was eradicated and the lymphoma showed regression within 6 to 24 months. In one patient transition of low-grade to high-grade gastric lymphoma occurred. CONCLUSIONS: these results, along with similar findings from other studies, suggest eradication of H. pylori should be the initial treatment of choice for low-grade B-cell gastric mucosa-associated lymphoid tissue type lymphoma in the early stages. The most appropriate duration of follow-up is unknown, but prolonged follow-up is indicated to detect recurrences.


Assuntos
Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori , Linfoma de Zona Marginal Tipo Células B/terapia , Neoplasias Gástricas/terapia , Adulto , Idoso , Antibacterianos/uso terapêutico , Feminino , Gastroscopia , Infecções por Helicobacter/complicações , Infecções por Helicobacter/patologia , Humanos , Linfoma de Zona Marginal Tipo Células B/microbiologia , Linfoma de Zona Marginal Tipo Células B/patologia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Neoplasias Gástricas/microbiologia , Neoplasias Gástricas/patologia
4.
Gastroenterol Hepatol ; 25(6): 383-6, 2002.
Artigo em Espanhol | MEDLINE | ID: mdl-12069699

RESUMO

AIMS: To evaluate the efficacy of 3-day intravenous Helicobacter pylori eradication therapy in patients with bleeding peptic ulcer associated with H. pylori infection. MATERIAL AND METHOD: We studied 53 patients admitted to hospital with bleeding of the upper gastrointestinal tract due to peptic ulcer and positive urease test over a 12-month period. After endoscopic diagnosis, intravenous pantoprazole (40 mg/12 hours), metronidazole (500 mg/8 hours) and amoxicillin-clavulanic acid (1,000 mg/200 mg/8 hours) was administered for 72 hours. The efficacy of eradication therapy was evaluated by 13C-urea breath test at least 2 months after the end of treatment. RESULTS: Fifty-one patients were included. Of these, 40 had duodenal ulcer and 11 had gastric ulcer. H. pylori eradication was achieved in 87.5% of those with duodenal ulcers and in 63.6% of those with gastric ulcers (p = 0.066). No adverse reactions or episodes of bleeding recurrence were found and none of the patients withdrew from treatment. CONCLUSIONS: The ultra-short course eradication therapy used in this study is highly effective. Its efficacy is similar to that of oral treatment and it avoids certain problems such as adverse effects and adherence to treatment.


Assuntos
Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori , Úlcera Péptica Hemorrágica/complicações , 2-Piridinilmetilsulfinilbenzimidazóis , Adulto , Idoso , Combinação Amoxicilina e Clavulanato de Potássio/administração & dosagem , Antibacterianos/administração & dosagem , Antiulcerosos/administração & dosagem , Benzimidazóis/administração & dosagem , Distribuição de Qui-Quadrado , Intervalos de Confiança , Interpretação Estatística de Dados , Quimioterapia Combinada/administração & dosagem , Úlcera Duodenal/complicações , Feminino , Infecções por Helicobacter/complicações , Humanos , Infusões Intravenosas , Masculino , Metronidazol/administração & dosagem , Pessoa de Meia-Idade , Omeprazol/análogos & derivados , Pantoprazol , Úlcera Péptica Hemorrágica/etiologia , Úlcera Gástrica/complicações , Sulfóxidos/administração & dosagem , Fatores de Tempo
5.
Gastroenterol Hepatol ; 20(3): 138-40, 1997 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-9162535

RESUMO

A case of angiodysplasia of the colon with clinical manifestation of massive rectal bleeding is presented. The activity and the severity of the life-threatening bleeding episode led to emergency exploratory laparotomy with intraoperative colonoscopy which was not diagnostic. Three years later, following multiple recurrent bleeding episodes and non diagnostic explorations, the localization of the hemorrhage was obtained by abdominal scintigraphy with 99mTc-red blood cells. Surgical removal of the affected area achieved definitive cure.


Assuntos
Angiodisplasia/diagnóstico por imagem , Doenças do Colo/diagnóstico por imagem , Hemorragia Gastrointestinal/etiologia , Angiodisplasia/complicações , Angiodisplasia/cirurgia , Doenças do Colo/complicações , Doenças do Colo/cirurgia , Feminino , Hemorragia Gastrointestinal/diagnóstico por imagem , Humanos , Pessoa de Meia-Idade , Cintilografia , Reto , Recidiva
8.
Rev. esp. enferm. dig ; Rev. esp. enferm. dig;101(2): 91-96, feb. 2009. tab
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-74347

RESUMO

Introducción: existen 2 tipos de proctitis actínica, una aguda autolimitada, que dura aproximadamente 3 meses y otra crónica que aparece a los meses o años de la radioterapia. La incidencia de proctitis actínica crónica es del 5-20% de los tumores prostáticos irradiados. Objetivo: evaluar la efectividad de la fulguración con argón plasma en el tratamiento de este tipo de proctitis. Material y método: estudio retrospectivo. Realizamos una búsqueda retrospectiva de aquellos pacientes diagnosticados de proctitis actínica entre 2004 y 2007. Analizamos el número de sesiones de fulguración con plasma de argón que fueron necesarias para la resolución de la sintomatología. Resultados: hemos hallado 22 pacientes con el diagnóstico de proctitis actínica. Diecinueve de los pacientes eran varones (86,4%) y tres mujeres (13,6%). De todos los pacientes 19 fueron diagnosticados de adenocarcinoma prostático (86,4%), una fue diagnosticada de carcinoma epidermoide de cérvix uterino (4,5%) y dos fueron diagnosticadas de adenocarcinoma de endometrio (9,1%). La media de sesiones de fulguración con plasma de argón necesarias para resolución de la clínica presentada fue de 2,58 (rango entre 1 y 7 sesiones) y con un mediana de 2 sesiones. Conclusión: en la literatura hay descritos múltiples tratamientos para la proctitis actínica. No obstante, ninguno de ellos ha presentado resultados demasiado prometedores. Nuestros resultados sugieren que la fulguración con plasma de argón es efectiva en el tratamiento de esta patología, consiguiendo una resolución rápida y mantenida de la sintomatología con pocas sesiones, además de presentar un buen perfil de seguridad(AU)


Introduction: there are two kinds of actinic proctitis - one is acute and self-limited, and lasts about 3 months; the other is chronic and develops months to years after radiation therapy. The incidence of chronic actinic proctitis is about 5-20% of radiated prostate tumors. Objective: to evaluate the effectiveness of argon plasma coagulation in the treatment of chronic actinic proctitis. Material and method: a retrospective search of patients with the diagnosis of actinic proctitis. The number of argon plasma coagulation therapies needed to achieve the symptom resolution was analyzed. Results: we found 22 patients with a diagnosis of actinic proctitis. Nineteen were males (86.7%) and three (13.6%) were females. Nineteen patients (86.4%) had a diagnosis of prostate adenocarcinoma, one had a diagnosis of squamous-cell cervix carcinoma (4.5%), and two had a diagnosis of endometrial carcinoma (9.1%). The mean number of coagulation sessions needed for symptom resolution was 2.58 (absolute range 1-7) with a median of 2 sessions. Conclusion: multiple treatments are described in the literature. None of them have shown promising results. Our results suggest that argon plasma coagulation is effective in the treatment of this condition, and achieves a rapid and sustained response with few sessions and a good safety profile(AU)


Assuntos
Humanos , Masculino , Feminino , Idoso , Fotocoagulação a Laser/tendências , Fotocoagulação a Laser , Hemorragia Gastrointestinal/cirurgia , Proctite/complicações , Proctite/cirurgia , Lesões por Radiação/complicações , Lesões por Radiação/cirurgia , Adenocarcinoma/radioterapia , Carcinoma de Células Escamosas/radioterapia , Hemorragia Gastrointestinal/etiologia , Hemostasia Cirúrgica/instrumentação , Neoplasias da Próstata/radioterapia , Estudos Retrospectivos , Displasia do Colo do Útero/radioterapia , Neoplasias do Colo do Útero/radioterapia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa